|
⚲
|
| Keyboard |
| US Venture Partners XII-A LP
✚
|
|
|---|---|
| CIK # | 0001754875 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001754875] | |
| 4 | [0001754875] | |
| D | [0001754875] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tansey Casey M | |
| ARS Pharmaceuticals Inc | |
| Presidio Management Group XII LLC | |
| US Venture Partners XII-A LP | |
| US Venture Partners XII LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ARS Pharmaceuticals Inc SBTX
Common Stock
|
2020-12-08 | Conversion | 14,677 | ||
|
ARS Pharmaceuticals Inc SBTX
Common Stock
|
2020-12-08 | Conversion | 90,335 | ||
|
ARS Pharmaceuticals Inc SBTX
Common Stock
|
2020-12-08 | Conversion | 289,198 | ||
|
ARS Pharmaceuticals Inc SBTX
Common Stock
|
2020-12-08 | Conversion | 1,779,969 | ||
|
ARS Pharmaceuticals Inc SBTX
Common Stock
|
2020-12-08 | Buy | 47,619 | $21.00 | 999,999 |
|
ARS Pharmaceuticals Inc SBTX
Preferred Series B Stock · derivative
|
2020-12-08 | Conversion | 6,609,027 | $0.00 | |
|
ARS Pharmaceuticals Inc SBTX
Preferred Series B Stock · derivative
|
2020-12-08 | Conversion | 335,417 | $0.00 | |
|
ARS Pharmaceuticals Inc SBTX
Preferred Series C Stock · derivative
|
2020-12-08 | Conversion | 1,073,793 | $0.00 | |
|
ARS Pharmaceuticals Inc SBTX
Preferred Series C Stock · derivative
|
2020-12-08 | Conversion | 54,496 | $0.00 |